911 Stock Overview
An investment holding company, engages in the sale of health-care products and electronic component products in Hong Kong.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Qianhai Health Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.30 |
52 Week High | HK$0.53 |
52 Week Low | HK$0.21 |
Beta | 0.33 |
11 Month Change | 7.14% |
3 Month Change | -25.00% |
1 Year Change | -30.23% |
33 Year Change | -70.00% |
5 Year Change | -87.18% |
Change since IPO | -99.50% |
Recent News & Updates
Shareholder Returns
911 | HK Retail Distributors | HK Market | |
---|---|---|---|
7D | -6.3% | -4.2% | -2.0% |
1Y | -30.2% | -19.2% | -4.9% |
Return vs Industry: 911 underperformed the Hong Kong Retail Distributors industry which returned -19.2% over the past year.
Return vs Market: 911 underperformed the Hong Kong Market which returned -4.9% over the past year.
Price Volatility
911 volatility | |
---|---|
911 Average Weekly Movement | 9.2% |
Retail Distributors Industry Average Movement | 10.0% |
Market Average Movement | 6.6% |
10% most volatile stocks in HK Market | 13.7% |
10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 911's share price has been volatile over the past 3 months.
Volatility Over Time: 911's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 16 | n/a | www.qianhaihealth.com.hk |
Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health-care products and electronic component products in Hong Kong. The company operates through Health-Care Products and Electronic Component Products segments. It offers Chinese herbal medicines, American ginseng, and other healthy drinks products.
Qianhai Health Holdings Limited Fundamentals Summary
911 fundamental statistics | |
---|---|
Market cap | HK$50.83m |
Earnings (TTM) | -HK$52.70m |
Revenue (TTM) | HK$961.29m |
0.1x
P/S Ratio-1.0x
P/E RatioIs 911 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
911 income statement (TTM) | |
---|---|
Revenue | HK$961.29m |
Cost of Revenue | HK$996.89m |
Gross Profit | -HK$35.60m |
Other Expenses | HK$17.10m |
Earnings | -HK$52.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.31 |
Gross Margin | -3.70% |
Net Profit Margin | -5.48% |
Debt/Equity Ratio | 0% |
How did 911 perform over the long term?
See historical performance and comparison